| Dr Eric R Anderson, DO | |
|
824 Illinois Ave, Stevens Point, WI 54481-3112 | |
| (715) 342-7500 | |
| Not Available |
| Full Name | Dr Eric R Anderson |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 16 Years |
| Location | 824 Illinois Ave, Stevens Point, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710131842 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 53398 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St Michaels Hospital | Stevens point, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aspirus Rhinelander And Tomahawk Hospitals And Clinics Inc | 9335059856 | 309 |
News Archive
Patient advocates are urging greater oversight of the private programs. In other news, a Philadelphia couple details their struggle to get health insurance for their son.
In addition to the Lancet's recent publication of an opinion piece and letter by 18 doctor association leaders about the potential health risks associated with climate change, the journal includes an editorial about sexual and reproductive health and climate change and a comment on the upcoming Copenhagen conference in December (9/19).
Across the globe, COVID-19 has infected more than 18 million people to date and has killed hundreds of thousands - and the United States has been hit especially hard. Although the U.S. comprises just 4.2% of the global population, it accounted for approximately 33% of all reported infections by the end of April.
Adocia, a biotechnology company specialized in the development of ‘best-in-class' medicines from already approved therapeutic proteins, in particular proteins and oncologic treatments, launches today a phase IIa clinical trial on its ultra-fast acting formulation of insulin Lispro (Humalog, Eli Lilly) using its proprietary technology BioChaperone).
After spending billions to switch from paper to digital records - much of it taxpayer subsidized through the economic stimulus package - providers say the systems often do not share information with competitors.
› Verified 3 days ago
| Entity Name | Aspirus Rhinelander & Tomahawk Hospitals & Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144991340 PECOS PAC ID: 9335059856 Enrollment ID: O20031126000706 |
News Archive
Patient advocates are urging greater oversight of the private programs. In other news, a Philadelphia couple details their struggle to get health insurance for their son.
In addition to the Lancet's recent publication of an opinion piece and letter by 18 doctor association leaders about the potential health risks associated with climate change, the journal includes an editorial about sexual and reproductive health and climate change and a comment on the upcoming Copenhagen conference in December (9/19).
Across the globe, COVID-19 has infected more than 18 million people to date and has killed hundreds of thousands - and the United States has been hit especially hard. Although the U.S. comprises just 4.2% of the global population, it accounted for approximately 33% of all reported infections by the end of April.
Adocia, a biotechnology company specialized in the development of ‘best-in-class' medicines from already approved therapeutic proteins, in particular proteins and oncologic treatments, launches today a phase IIa clinical trial on its ultra-fast acting formulation of insulin Lispro (Humalog, Eli Lilly) using its proprietary technology BioChaperone).
After spending billions to switch from paper to digital records - much of it taxpayer subsidized through the economic stimulus package - providers say the systems often do not share information with competitors.
› Verified 3 days ago
| Entity Name | Divine Savior Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124083894 PECOS PAC ID: 5799684007 Enrollment ID: O20040225000909 |
News Archive
Patient advocates are urging greater oversight of the private programs. In other news, a Philadelphia couple details their struggle to get health insurance for their son.
In addition to the Lancet's recent publication of an opinion piece and letter by 18 doctor association leaders about the potential health risks associated with climate change, the journal includes an editorial about sexual and reproductive health and climate change and a comment on the upcoming Copenhagen conference in December (9/19).
Across the globe, COVID-19 has infected more than 18 million people to date and has killed hundreds of thousands - and the United States has been hit especially hard. Although the U.S. comprises just 4.2% of the global population, it accounted for approximately 33% of all reported infections by the end of April.
Adocia, a biotechnology company specialized in the development of ‘best-in-class' medicines from already approved therapeutic proteins, in particular proteins and oncologic treatments, launches today a phase IIa clinical trial on its ultra-fast acting formulation of insulin Lispro (Humalog, Eli Lilly) using its proprietary technology BioChaperone).
After spending billions to switch from paper to digital records - much of it taxpayer subsidized through the economic stimulus package - providers say the systems often do not share information with competitors.
› Verified 3 days ago
| Entity Name | Aspirus Stevens Point Hospital & Clinics, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538112230 PECOS PAC ID: 1850358938 Enrollment ID: O20041210000558 |
News Archive
Patient advocates are urging greater oversight of the private programs. In other news, a Philadelphia couple details their struggle to get health insurance for their son.
In addition to the Lancet's recent publication of an opinion piece and letter by 18 doctor association leaders about the potential health risks associated with climate change, the journal includes an editorial about sexual and reproductive health and climate change and a comment on the upcoming Copenhagen conference in December (9/19).
Across the globe, COVID-19 has infected more than 18 million people to date and has killed hundreds of thousands - and the United States has been hit especially hard. Although the U.S. comprises just 4.2% of the global population, it accounted for approximately 33% of all reported infections by the end of April.
Adocia, a biotechnology company specialized in the development of ‘best-in-class' medicines from already approved therapeutic proteins, in particular proteins and oncologic treatments, launches today a phase IIa clinical trial on its ultra-fast acting formulation of insulin Lispro (Humalog, Eli Lilly) using its proprietary technology BioChaperone).
After spending billions to switch from paper to digital records - much of it taxpayer subsidized through the economic stimulus package - providers say the systems often do not share information with competitors.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eric R Anderson, DO 824 Illinois Ave, Stevens Point, WI 54481-3112 Ph: (715) 342-7500 | Dr Eric R Anderson, DO 824 Illinois Ave, Stevens Point, WI 54481-3112 Ph: (715) 342-7500 |
News Archive
Patient advocates are urging greater oversight of the private programs. In other news, a Philadelphia couple details their struggle to get health insurance for their son.
In addition to the Lancet's recent publication of an opinion piece and letter by 18 doctor association leaders about the potential health risks associated with climate change, the journal includes an editorial about sexual and reproductive health and climate change and a comment on the upcoming Copenhagen conference in December (9/19).
Across the globe, COVID-19 has infected more than 18 million people to date and has killed hundreds of thousands - and the United States has been hit especially hard. Although the U.S. comprises just 4.2% of the global population, it accounted for approximately 33% of all reported infections by the end of April.
Adocia, a biotechnology company specialized in the development of ‘best-in-class' medicines from already approved therapeutic proteins, in particular proteins and oncologic treatments, launches today a phase IIa clinical trial on its ultra-fast acting formulation of insulin Lispro (Humalog, Eli Lilly) using its proprietary technology BioChaperone).
After spending billions to switch from paper to digital records - much of it taxpayer subsidized through the economic stimulus package - providers say the systems often do not share information with competitors.
› Verified 3 days ago
Jay J Rusek, MD Surgery Medicare: Medicare Enrolled Practice Location: 824 Illinois Avenue, Stevens Point, WI 54481 Phone: 715-342-7500 | |
Kellie Jones-monahan, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 4100 State Highway 66, Stevens Point, WI 54482 Phone: 715-343-7700 | |
Mr. Michael W Cavanaugh, P.A.-C Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 Vincent St, Stevens Point, WI 54481 Phone: 715-344-0701 Fax: 715-344-4494 | |
Dr. Christopher Willard Swiecki, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 824 Illinois Ave, Stevens Point, WI 54481 Phone: 715-342-7765 Fax: 715-342-7963 |